ID Screen® SARS-CoV-2-N IgG Indirect ELISA

A highly reliable serology test to detect IgG antibodies against SARS-CoV-2.

Indirect semi-quantitative ELISA for the specific detection of IgG antibodies against the nucleocapsid of SARS-CoV-2 in human serum and plasma.

 

Reliable:

  • Approved by French authorities further to its evaluation by the French National Reference Centre
  • High sensitivity and specificity (99.9%) ensures accurate results, with clear discrimination of positive and negative samples
  • Excellent specificity and high positive predictive value, even in low prevalence areas, means a positive result reliably indicates if a person has been exposed to the virus and if the patient has developed antibodies

Rapid and easy-to-use:

  • Use manually or with any open automated immunoassay platform
  • Ready-to-use reagents
  • Results in 95 minutes
  • Possibility to operate on inactivated serum/plasma samples to guarantee operator’s safety

This product is CE marked and available for immediate shipping.

 

Download the IDvet Press Release of May 7th, 2020

Download the Product Presentation

Specifications
MethodSemi-quantitative indirect ELISA
SpeciesHumans
SpecimensSerum or plasma
Coated antigenPurified recombinant antigen
ConjugateProtein G-HRP conjugate (concentrated 10X)
Ordering information
Product codeSARSCOV2S-4PSARSCOV2S-8P
Kit format4 plates8 plates
Reactions384768
Plate format12 x 8-well strips12 x 8-well strips